Solventum Corporation (NYSE:SOLV) Given Consensus Recommendation of “Hold” by Analysts

Shares of Solventum Corporation (NYSE:SOLV) have received a consensus rating of “Hold” from the fourteen brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $83.6667.

A number of analysts recently commented on the stock. BMO Capital Markets started coverage on shares of Solventum in a research note on Wednesday, July 8th. They set a “market perform” rating and a $81.00 price target on the stock. Weiss Ratings lowered shares of Solventum from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, June 26th. KeyCorp boosted their target price on shares of Solventum from $92.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. UBS Group downgraded Solventum from a “buy” rating to a “neutral” rating and set a $50.00 target price on the stock. in a research report on Thursday, May 14th. Finally, Rothschild & Co Redburn started coverage on Solventum in a report on Tuesday, March 24th. They issued a “sell” rating and a $60.00 price target for the company.

Solventum Stock Up 1.0%

SOLV stock opened at $77.48 on Tuesday. The stock has a fifty day moving average of $76.44 and a 200-day moving average of $74.26. Solventum has a fifty-two week low of $62.38 and a fifty-two week high of $88.20. The company has a market capitalization of $13.42 billion, a price-to-earnings ratio of 9.50, a PEG ratio of 1.18 and a beta of 0.66. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.75 and a current ratio of 1.07.

Solventum (NYSE:SOLV) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.35 by $0.13. Solventum had a net margin of 17.33% and a return on equity of 23.51%. The business had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the prior year, the firm earned $1.34 earnings per share. The company’s revenue was down 3.0% compared to the same quarter last year. Solventum has set its FY 2026 guidance at 6.600-6.600 EPS. As a group, equities research analysts predict that Solventum will post 6.58 earnings per share for the current year.

Institutional Investors Weigh In On Solventum

Institutional investors and hedge funds have recently modified their holdings of the company. Hilltop National Bank grew its stake in Solventum by 71.3% during the fourth quarter. Hilltop National Bank now owns 310 shares of the company’s stock valued at $25,000 after acquiring an additional 129 shares in the last quarter. CrossGen Wealth LLC purchased a new stake in Solventum in the 4th quarter worth approximately $25,000. Measured Wealth Private Client Group LLC purchased a new stake in Solventum in the 3rd quarter worth approximately $25,000. Clearstead Trust LLC boosted its holdings in Solventum by 61.0% in the 1st quarter. Clearstead Trust LLC now owns 396 shares of the company’s stock valued at $26,000 after purchasing an additional 150 shares during the period. Finally, JNBA Financial Advisors boosted its holdings in Solventum by 205.4% in the 4th quarter. JNBA Financial Advisors now owns 339 shares of the company’s stock valued at $27,000 after purchasing an additional 228 shares during the period.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.